TNF and rheumatoid arthritis: Indeed, in patients with RA, baseline TNF is associated with the clinical response to infliximab (TNF blocker): a higher dose is necessary in patients with a high baseline TNF, whereas lower doses of infliximab are sufficient for those with a low baseline TNF 35, 36.